Methods for Risk Assessment of Transgenic Plants: III. Ecological risks and prospects of transgenic plants, where do we go from here? A dialogue between biotech industry and science
May 28, 2010 by biotechconnection.com · Leave a Comment
Product DescriptionDiscusses ecological risks and prospects of transgenic plants. Presents the discussion sessions as well as the scientific contributions and thus mirrors the risk assessment debate based not on exaggerated negative scenarios but on critical science and hard data.
Order from Amazon –> Methods for Risk Assessment of Transgenic Plants: III. Ecological risks [...]
Kinase Therapeutics: Pipeline Assessment and Commercial Prospects
May 5, 2010 by biotechconnection.com · Leave a Comment
The number of kinase inhibitors entering clinical development has increased significantly in recent years. In addition to major pharmaceutical and biotech companies, an increasing number of emerging companies are focusing on their development. By 2020, small-molecule kinase inhibitors could generate annual revenues > $25 billion.
This report assesses:
– R&D considerations specific to targeting kinases – [...]
Reportlinker Adds Drug Delivery Technologies: Players, Products & Prospects to 2018
May 5, 2010 by biotechconnection.com · Leave a Comment
Reportlinker Adds Drug Delivery Technologies: Players, Products & Prospects to 2018
Reportlinker.com announces that a new market research report is available in its catalogue:
Read more on PR Newswire via Yahoo! Finance
Future prospects of enzyme engineering and enzyme technology
March 8, 2010 by biotechconnection.com · Leave a Comment
Future prospects of enzyme engineering
Enzyme engineering is the recent technology growing rapidly due to its higher application in a lot of fields and due to having bright and clear future vision. A most exciting development over the last few years is [...]
